Medtronic Acquires Scientia Vascular | NE72
Article excerpt
Highlighted: the sentence this signal was extracted from
Medtronic announced that it has completed the acquisition of Scientia Vascular, a privately held developer of access products for the treatment of complex neurovascular conditions. The company stated that the acquisition is valued at $550 million, subject to customary adjustments, with potential undisclosed post-acquisition payments tied to earn-outs and milestones. In March 2026, Medtronic announced a definitive agreement to acquire Scientia Vascular. According to the press release, Scientia's portfolio of guidewires and catheters can be seamlessly integrated with Medtronic's existing range of neurovascular products. «Since its founding, Scientia has been guided by a commitment to improving the lives of patients and supporting the physicians who care for them», commented Rick Randall, CEO of Scientia, in the press release. «Joining Medtronic represents an exciting next step for our team, as their mission is closely aligned with the values that have guided Scientia from the beginning. With Medtronic's global scale, we look forward to bringing this technology to more physicians and reaching more patients worldwide». Linnea Burman, Senior Vice President and President of the Neurovascular business at Medtronic, which is part of Medtronic's Neuroscience Portfolio, stated: «The addition of Scientia's access technologies reinforces our ability to simplify complex neurovascular...
Keep reading with a free account
The rest of this article, and every signal for Medtronic, is in your free account.
